SCIENTIFIC PROGRAMME

INTERNATIONALSYMPOSIUM ONDIABETES17

13th - 14th January 2018Grand Hyatt, Kalina, Mumbai, India

www. i d s i . i n

CME CrEdits will bE AwArdEd

• AllparticipantswhoaredelegateswillneedtofilltheCMEevaluationformandsubmititattheregistrationcounterafter6.00pmon14thJanuary,2018inpersonandthecertificatewillbemailedtothem.

• ValidPhotoIDisCompulsory.• Anyparticipantwhoattendspartoftheprogramorcannotwaitduetotraveletc.willnotgetthecertificate.• AlldelegatesmustfilltheCMEevaluationformandattendthefullconference.

Presentation of Certificates

ANNUAl MEEtiNG 2018

IndianAcademyofDiabetes(IAD)•

AcademicPartner

TheAssociationofPhysiciansofIndia•

DiabeticAssociationofIndia•

CoUrsE dirECtors Prof.K.SreekumaranNair Prof.A.K.Das DavidMurdockDoleProfessorofMedicine, RetiredDeanandDirector, MayoClinicCollegeofMedicine, Dept.ofMedicine,JIPMER, DivisionofEndocrinology,MayoClinic,200FirstStreet Puducherry,India S.W.,Rochester,MN55905USA

orGANisiNG CHAirMAN orGANisiNG sECrEtAry

Dr.ShashankR.Joshi Dr.BanshiSaboo•

MMC obsErvErDr.AkilSulemanContractor

•AUdio-visUAl dirECtor

Dr.DeepakJumaniemail:deepak.jumani@gmail.com

•EvENt Co-ordiNAtor

Ms.RubySound•

EvENt MANAGErMr.H.N.Trivedi

Tel.:022-66605059•email:info@eventsinmumbai.com

INDIAN ACADEMY OF DIABETESANNUAL MEETING 2017AnnuAl Meeting 2018

Dear friends,

It gives me great pleasure to welcome you all to Mumbai- the capital of Maharashtra and heartbeat of India for a rich scientific program.This program has been set up by Indian clinicians with medical experts from the USA,

and aims to enrich your wisdom and clinical sixth sense in all areas of diabetes therapy, research and clinical diabetes. Apart from the latest cutting edge science and path breaking discoveries, Indian work in each therapy area will be shared in some unique formats. A special focus is our “ Made in India” lectures where discoveries and the use of medicine of Indian Innovations will be presented.

This is the 17th Edition of the International Symposium of Diabetes. This meeting originally started 17 years ago as the Mayo Clinic Meeting in Kochi by Prof Robert Rizza and Prof K Sreekumarnan Nair - as a capacity building program to update Indian physicians on diabetes. The Indian Academy of Diabetes, The Association of Physicians of India and Diabetic Association of India are the academic partners of our current meeting. Like every year, we have applied for Medical Council awarded 4 credit points and all participants are expected to fill the CME Evaluation forms at the end of the meeting. WIDF will also be announcing awards for outstanding researchers and innovators. The Indian Academy of Diabetes is giving out awards for “Life time Achievement”, “Unique Indian Innovations”, “Community service”, “Education” and “Rising star”. The idea of these awards is to generate more Indian evidence, promote younger generations and better the care of diabetes in India.

This year, the WIDF GLOBAL Oration is by Prof Juleen Zierath, President EASD from Sweden who will speak on “The role of diet and exercise in the transgenerational epigenetic landscape of Type 2 Diabetes”. The WIDF AWARD Oration is by Dr. Nikhil Tandon, New Delhi who will deliver the talk “Nutrition and diabetes in India: Learning from CARRS Surveillance Study”. The Prestigious S S Ajgaokar Oration is by Dr. Ketan Dhatariah, UK on “Management of Diabetic Keto-acidosis and hyperosmolar state”, the MMS Ahuja Oration will be by Dr Vijay Panikar on “When insulin is not an option in Type 2 diabetes”. Prof Anil Bhoraskar will speak on “Individualised diabetes care – KISS : Keep it Simple and Safe” in the RV Sathe Oration. The prestigious BS Raheja Memorial Oration will be delivered by Dr. Nihal Thomas from Vellore on “Diabetes in India: the lean, the gene, what does it mean: Vellore Visions”.

We have a special Foot Workshop where in The state of the art lecture on “Charcot Foot” will be delivered by Dr. Ketan Dhatariya from UK. As our Indian prime minister is promoting Yoga, a special session on Stress management and Yoga will be conducted by Indian and US experts.

We are fortunate to have Prof Juleen Zierath, President EASD from Sweden as the Chief Guest of this scientific meeting.

We are all here with a common goal and common mission- to make lives of our Diabetics better. We all are committed to make India the Diabetes capital of the World. My prevention mantra for Diabetes prevention is “Eat Less, Eat Slowly, Eat on Time, Eat Right, Walk More, Sleep well & on time and Smile”. Happy Learning.

Warm Welcome

Prof. shashank r. Joshi, MD,DM,FICP,FACP(USA),FACE(USA),FRCP(London,EdinburghandGlasgow)ORGANISINGCHAIRMAN

Endocrinologist,JoshiClinic,LilavatiHospital,ApolloSugarClinic&BhatiaHospitalPresident,AssociationofPhysiciansofIndia(API)(2014-15)EmeritusEditor,JAPIPresident,IndianAcademyofDiabetesPastPresident,HypertensionSocietyofIndiaPast-President,EndocrineSocietyofIndia(2015-16)PastPresident,RSSDI(ResearchSocietyfortheStudyofDiabetesinIndia2011)PastPresident,AIAARO(AllIndiaAssociationofAdvancementforResearchinObesity)ChapterChairIndiaAACEPadmaShriAwardee2014

National Faculty

SaritaBajaj

SMBandukwala

BRBansode

AMBhagwati

AnilBhoraskar

HardikChandarana

RajeevChawla

DeepakDalal

AKDas

NarayanDeogaonkar

VaishaliDeshmukh

RohitDeshpande

UmakantDeshpande

PradeepGadge

KalyanGangopadhyay

VijayGarg

BhushanHemade

SaurabhHemade

ShashankRJoshi

AjayKumar

BMMakkar

SudhakarMhaskar

AnoopMisra

AmbrishMithal

VMohan

RajniMullarpattan

ShirshenduPal

JayantPanda

VijayPanikar

UdayPhadke

SandeepRai

ARRamachandran

BanshiSaboo

JanaJayaprakashSai

SMSapatnekar

AmitSaraf

SureshSawardekar

DSelvaraj

KrishnaSeshadri

ParagShah

SanjivShah

SheetalShah

SiddharthShah

ManjunathShankarappa

JaideepShinde

RubySound

VirajSuvarna

ManishaTalim

NikhilTandon

HemantThacker

NihalThomas

MangeshTiwaskar

JimitVadgama

VijayVishwanathan

JitenVoraUK

KetanDhatariyaUK

SumitBhagraMayo Clinic, USA

AnjaliBhagra Mayo Clinic, USA

StephenAtkins UK

YehudaHandelsman LA, USA

PäiviMariaPaldániusFinland

YogishC.KudvaMayo Clinic, USA

17th International Symposium on Diabetes13th-14thJanuary2018•GrandHyatt,Kalina,Mumbai,India

CourSe DIreCtorS

Prof. K. srEEKUMArAN NAirDavidMurdockDoleProfessorofMedicine,

MayoClinicCollegeofMedicine,DivisionofEndocrinology,MayoClinic,

200FirstStreetS.W.,Rochester,MN55905USA

Prof. A.K. dAsRetiredDeanandDirector,

Dept.ofMedicine,JIPMER,Puducherry,INDIAProfessorofMedicine&ProfessorandHeadofEndocrinology,

PondicherryInstituteofMedicalSciences

INvIteD SpeakerS

theme managing asian Indian Diabetic 2018

WIDF oratIoN

Prof. JUlEEN ZiErAtHProfessor,IntegrativePhysiology,

DepartmentofMolecularMedicineandSurgery,KarolinskaInstitutet,Stockholm,SwedenPresident,EuropeanAssociationforthe

StudyofDiabetes

08.3009.00

iNAUGUrAtioN witH lAMP liGHtiNG ANd widf AwArd CErEMoNyChief Guest: Juleen Zierath, President EASD K sreekumaran Nair, Mayo Clinic, USA shashank Joshi, Mumbai sumit bhagra, Mayo Clinic, USA banshi saboo, Ahmedabad

09.0009.45

widf GlobAl orAtioNChairpersons: K sreekumaran Nair, Mayo Clinic, USA shashank Joshi, Mumbai

Theroleofdietandexerciseinthetransgenerationalepigeneticland-scapeofType2DiabetesJuleen Zierath, Sweden

09.4510.15

widf AwArd orAtioNChairpersons: K sreekumaran Nair, Mayo Clinic, USA sumit bhagra, Mayo Clinic, USA

NutritionanddiabetesinIndia:LearningfromCARRSSurveillanceStudyNikhil tandon, New Delhi

Chairpersons: Amit saraf, Mumbai banshi saboo, Ahmedabad

10.1510.35

AGIs:ItsplaceinmoderndaydiabetesmanagementParag shah, Ahmedabad

10.3510.55

Hypoglycaemiaininsulintreateddiabetespatients:challenges&solutionsstephen Atkins, UK

10.5511.15

Initiating&intensifyinginsulintherapy:Placeforpremixinsulinsinclinicalcarev. Mohan, Chennai

11.1511.35

Ultra-shortactinginsulins:futuredirections&clinicalpossibilitiesshashank Joshi,Mumbai

Scientific programmeDay 1 • Saturday • 13th January 2018 • Grand Hyatt, Kalina, Mumbai, INDIa

17th Annual Meeting of indian Academy of diabetes and MENd UpdateIn Collaboration with the Association of Physicians of india & diabetic Association of india

Chairpersons: siddharth shah, Mumbai deepak dalal, Mumbai shashank Joshi, Mumbai

11.3512.05

Sarcopenia2018K sreekumaran Nair, Mayo Clinic, USA

12.0512.25

DiabetesspecificnutritionandtransculturalalgorithmforIndiansv. Mohan, Chennai

12.2512.45

RoleofFunctionalFoodssudhakar Mhaskar, Mumbai

12.4501.00 ChairpersonsRemarksandDemonstration

01.0002.00 LUNCH

Chairpersons: Anjeli bhagra, USA br bansode, Mumbai d. selvaraj, Tuticorin

02.0002.20

PrecisionDiabeteshasbecomearealityv Mohan,Chennai

02.2002.40

OnceweeklyGLP-1RAanAWARDtoT2DManagementKalyan Gangopadhyay, Kolkata

02.4003.00

PneumococcalVaccineinDiabetesJayant Panda, Cuttak

Chairpersons: sumit bhagra, USA sandeep rai, Navi Mumbai Jana Jayaprakash sai, Hyderabad

03.0003.20

PostCANVASErainT2DMmanagement:Glycemiccontrolandbeyondyehuda Handelsman, USA

03.2003.40

DementiaandDiabetesK sreekumaran Nair, Mayo Clinic, USA

03.4004.00

Artificialpancreas:closingtheloopyogish Kudva,Mayo Clinic, USA

Chairpersons: rajeev Chawla, New Delhi Umakant deshpande, Mumbai

04.0004.15

GliflozinFDCs-Fivedesiredcharacteristicsviraj suvarna, Mumbai

04.1504.30

Saroglitazar–IndianperspectivesHemant thacker, Mumbai

Scientific programmeDay 1 • Saturday • 13th January 2018 • Grand Hyatt, Kalina, Mumbai, INDIa

Chairpersons: banshi saboo, Ahmedabad Amit saraf, Mumbai

04.3004.45

Mealtimeinsulin:theartandscienceofintensificationrajeev Chawla, New Delhi

04.4505.00

15yearsofglargineinsulininIndia:EmpoweringphysiciansbM Makkar, New Delhi

05.0005.15

Nextgenerationinsulin:RedefiningcontrolKrishna seshadri, Chennai

05.1505.45

ss AJGAoNKAr orAtioN

Chairpersons:Jimit vadgama,Surat vijay Panikar,Mumbai

ManagementofDiabeticKeto-acidosisandhyperosmolarstateKetan dhatariah, UK

05.4506.15

MMs AHUJA orAtioN

Chairpersons:Krishna seshadri,Chennai bM Makkar,New Delhi

WheninsulinisnotanoptioninType2diabetesvijay Panikar, Mumbai

06.1506.45

CaseBaseddiscussions

Moderator: sumit bhagra, Mayo Clinic, USA

Anjeli bhagra, MayoClinic,USA Ketan dhatariya, UK yogish Kudva, UK shashank Joshi, Mumbai Krishna seshadri, Chennai

Scientific programmeDay 1 • Saturday • 13th January 2018 • Grand Hyatt, Kalina, Mumbai, INDIa

Scientific programmeDay 2 • Sunday • 14th January 2018 • Grand Hyatt, Kalina, Mumbai, INDIa

Chairpersons: Anjeli bhagra, Mayo Clinic, USA ruby sound, Mumbai

08.3009.00

ScienceofYoga:ResearchbasedevidenceonyogicpracticesandeffectManjunath shankarappa, Bengaluru

Chairpersons: Narayan deogaonkar, Nashik Manisha talim, Mumbai

09.0009.20

ModernSUsincombinations:ASafeandSmartapproachsarita bajaj, Allahabad

09.2009.40

DiabetesandInflammationUday Phadke, Pune

09.4010.00

EvolvinglandscapeofCVOTswithDPP4i;focusonupcomingCVOTsvaishali deshmukh, Pune

Chairpersons: vijay Garg, Ujjain Nihal thomas, Vellore

10.1010.25

Ensuringvascularlegacybenefitsforhypertensivediabetics–StrongevidencefromADVANCE-ONvijay vishwanathan, Chennai

10.2510.40

EvolvingstandardsofCareinDiabetes–thecasepostEMPA-REGOUT-COMEA ramachandran, Chennai

Chairpersons: A r ramachandran, Chennai sandeep rai, Navi Mumbai

10.4011.00

Non-obesePatientswithDiabetes:Heterogeneity,PhenotypeandApproachtomanagementAnoop Misra, New Delhi

11.0011.20

PositioningGliptinsinthecontinuumofT2DMManagementAmbrish Mithal, NewDelhi

11.2011.40

EstablishedClass,NovelInsights:HowGliptinsContinuedtoSurpriseUsoverthelastdecadeAjay Kumar, Patna

11.4012.10

rv sAtHE orAtioN

Chairpersons:sM sapatnekar, Mumbai Anjeli bhagra, Mayo Clinic, USA

Individualiseddiabetescare–KISS:KeepitSimpleandSafeAnil bhoraskar, Mumbai

Scientific programmeDay 2 • Sunday • 14th January 2018 • Grand Hyatt, Kalina, Mumbai, INDIa

Chairpersons: shirshendu Pal, Siliguri sM bandukwala, Mumbai

12.1012.25

DPP-4i:ThePast,PresentandFuturePäivi Maria Paldánius, Finland

12.2512.30

iAd and widf Award CeremonyK sreekumaran Nair, Mayo Clinic, USA shashank Joshi, Mumbai banshi saboo, Ahmedabad sumit bhagra, Mayo Clinic, USA

12.3001.00

BSRAHEJAMEMORIALORATION

Chairpersons: K sreekumaran Nair, Mayo Clinic, USA AK das, Puducherry

DiabetesinIndia:thelean,thegene,whatdoesitmean:VelloreVisionsNihal thomas, Vellore

01.0002.00 LUNCH

Chairpersons: Mangesh tiwaskar, Mumbai AM bhagwati, Mumbai

02.0002.30

Dapagliflozin:wherearewetodayJiten vora, UK

Chairpersons: sanjiv shah, Mumbai Pradeep Gadge, Mumbai

02.3002.50

Diabetes,NephropathyandCVD:connectingthelinkAK das, Puducherry

02.5003.10

Ensuringvascularlegacybenefitsforhypertensivediabetics–StrongevidencefromADVANCE-ONbanshi saboo, Ahmedabad

03.1003.30

DiabeticDyslipidemia:What’snew?sumit bhagra, Mayo Clinic, USA

Chairpersons: suresh sawardekar, Mumbai Jaideep shinde, Mumbai

03.3003.50

AddressingthePressingNeedsofDiabetes:IndianScenarioMangesh tiwaskar, Mumbai

03.5004.20

DiabetesandStress:AtwoWayConnectionAnjeli bhagra, Mayo Clinic, USA

04.2004.35

TherapeuticlifestylemanagementinDiabetessanjiv shah, Mumbai

Scientific programmeDay 2 • Sunday • 14th January 2018 • Grand Hyatt, Kalina, Mumbai, INDIa

Chairpersons: deepak Jumani, Mumbai Amit saraf, Mumbai Mangesh tiwaskar, Mumbai

04.3505.05

UpdateonBetaCellTransplantation/replacementforType1diabetesyogish Kudva, Mayo Clinic, USA

05.0505.35

DiabetesandBoneHealthPäivi Maria Paldánius, Finland

Hall B (Grand Salon)

foot worKsHoP

Moderator: rohit deshpande, Mumbai AK das, Puducherry Hardik Chandarana, Ahmedabad

introduction & welcome

02.0002.30

WhatisFoot&itsbasiccomplicationindailypractice?sheetal shah, Mumbai

02.3003.00

STATEOFTHEARTLECTURE

CharcotFootKetan dhatariya, UK

03.0003.20

DiabeticNeuropathy:ImplicationsonFootStructure&Functionrajni Mullarpattan, Mumbai

03.2003.40

HowtomanagepainfulDiabeticFootsM bandukwala, Mumbai

03.4004.00

Diabetes&PVD–ImportanceinFootCareHardik Chandarana, Ahmedabad

04.0004.20

Prescription&customizationofOrthoticSupportsaurabh Hemade, Mumbai

04.2004.40

EstablishingaDiabeticFootClinicbhushan Hemade, Mumbai

04.4005.00 PanelDiscussion

Sponsors

MSDSUN

Sanofi India Ltd.USV

Eris Life SciencesNovo Nordisk

NovartisBoehringer Ingelheim

GlenmarkEmcure

Zydus CadilaAstra Zeneca

Dr. Reddys LaboratoriesAlkem

MaricoJanssen (Johnson & Johnson)

Life Scan (Johnson & Johnson)Abbott Nutrition

Abbott HealthcareWockhardt

SerdiaLupin

TorrentIntasCiplaAristo

Eli LillyAbbott India Ltd.

GSKIPCA LabsMicro LabsZuventus

Abbott Diabetes CareBayer ZydusFranco India

E. MerckIndico remedies

SKM-Vitabolik PharmaceuticalsPfizer

CurataseMediNexus and IJCP

All Indian attendees are requested to strictly follow MCI Code of ethics

MEdiCAl CoUNCil of iNdiAAMENdMENt NotifiCAtioN

New delhi, the 10th december, 2009No.MCI-211(1)/2009(Ethics)/55667-InexerciseofthepowersconferredbySection33oftheIndianMedicalCouncilAct,1956(102of1956),theMedicalCouncilofIndiawiththeprevioussanctionoftheCentralGovernment,herebymakesthefollowingRegulationstoamendthe“IndianMedicalCouncil(ProfessionalConduct,EtiquetteandEthics)Regulations,2002:-

1. i. TheseRegulationsmaybecalledthe“IndianMedicalCouncil(ProfessionalConduct,EtiquetteandEthics)(Amendment)Regulations,2009-Part-I”.

ii. TheyshallcomeintoforcefromthedateoftheirpublicationintheOfficialGazette.

2. Inthe“IndianMedicalCouncil(ProfessionalConduct,EtiquetteandEthics)Regulations,2002”,thefollowingadditions/modifications/deletions/substitutions,shallbe,asindicatedtherein:-

3. Thefollowingclauseshallbeaddedafterclause6.7:-

“6.8Codeofconduct fordoctorsandprofessionalassociationofdoctors in their relationshipwithpharmaceuticalandalliedhealthsectorindustry.

6.8.1IndealingwithPharmaceuticalandalliedhealthsectorindustry,amedicalpractitionershallfollowandadheretothestipulationsgivenbelow:-

a. Gifts:Amedicalpractitionershallnotreceiveanygiftfromanypharmaceuticaloralliedhealthcareindustryandtheirsalespeopleorrepresentatives.

b. Travelfacilities:Amedicalpractitionershallnotacceptanytravelfacilityinsidethecountryoroutside,includingrail,air,ship,cruisetickets,paidvacationsetc.fromanypharmaceuticaloralliedhealthcareindustryortheirrepresentativesforselfandfamilymembersforvacationorforattendingconferences,seminars,workshops,CMEprogrammeetcasadelegate.

c. Hospitality:Amedicalpractitionershallnotacceptindividuallyanyhospitalitylikehotelaccommodationforselfandfamilymembersunderanypretext.

d. Cashormonetarygrants:Amedicalpractitionershallnotreceiveanycashormonetarygrantsfromanypharmaceuticalandalliedhealthcareindustryforindividualpurposeinindividualcapacityunderanypretext.Fundingformedicalresearch,studyetc.canonlybereceivedthroughapprovedinstitutionsbymodalitieslaiddownbylaw/rules/guidelinesadoptedbysuchapprovedinstitutions,inatransparentmanner.Itshallalwaysbefullydisclosed.

e. MedicalResearch:Amedicalpractitionermaycarryout,participatein,workinresearchprojectsfundedbypharmaceuticalandalliedhealthcareindustries.Amedicalpractitionerisobligedtoknowthatthefulfillmentofthefollowingitems(i)to(vii)willbeanimperativeforundertakinganyresearchassignment/projectfundedbyindustry–forbeingproperandethical.Thus,inacceptingsuchapositionamedicalpractitionershall:-

i. Ensurethattheparticularresearchproposal(s)hastheduepermissionfromthecompetentconcernedauthorities.

ii. Ensurethatsucharesearchproject(s)hastheclearanceofnational/state/institutionalethicscommittees/bodies.

iii. Ensurethatitfulfilsallthelegalrequirementsprescribedformedicalresearch.

iv. Ensurethatthesourceandamountoffundingispubliclydisclosedatthebeginningitself.

v. Ensurethatpropercareandfacilitiesareprovidedtohumanvolunteers,iftheyarenecessaryfortheresearchproject(s).

vi. Ensurethatundueanimalexperimentationsarenotdoneandwhenthesearenecessarytheyaredoneinascientificandahumaneway.

vii. EnsurethatwhileacceptingsuchanassignmentamedicalpractitionershallhavethefreedomtopublishtheresultsoftheresearchinthegreaterinterestofthesocietybyinsertingsuchaclauseintheMoUoranyotherdocument/agreementforanysuchassignment.

f. MaintainingProfessionalAutonomy:Indealingwithpharmaceuticalandalliedhealthcareindustryamedicalpractitionershallalwaysensurethatthereshallneverbeanycompromiseeitherwithhis/herownprofessionalautonomyand/orwiththeautonomyandfreedomofthemedicalinstitution.

g. Affiliation: Amedical practitionermaywork for pharmaceutical and allied healthcare industries in advisory capacities, asconsultants,asresearchers,astreatingdoctorsorinanyotherprofessionalcapacity.Indoingso,amedicalpractitionershallalways:

i. Ensurethathisprofessionalintegrityandfreedomaremaintained.

ii. Ensurethatpatientsinterestarenotcompromisedinanyway.

iii. Ensurethatsuchaffiliationsarewithinthelaw.

iv. Ensurethatsuchaffiliations/employmentsarefullytransparentanddisclosed.

h. Endorsement:Amedicalpractitionershallnotendorseanydrugorproductoftheindustrypublically.Anystudyconductedontheefficacyorotherwiseofsuchproductsshallbepresentedtoand/orthroughappropriatescientificbodiesorpublishedinappropriatescientificjournalsinaproperway”.

(lt. Col. (retd.) dr. A.r.N. setalvad)Secretary,MedicalCouncilofIndia

FootNote:ThePrincipalRegulationsnamely,“IndianMedicalCouncil(ProfessionalConduct,EtiquetteandEthics)Regulations,2002”werepublishedinPart–III,Section(4)oftheGazetteofIndiaonthe6thApril,2002,andamendedvideMCInotificationdated22/02/2003&26/05/2004.

URV

I CO

MPU

GRA

PHIC

S

022-

2494

586

3

urvi

@ur

vi.c

c